RE: [NMusers] Reporting Modeling Results

From: Carl Kirkpatrick <C.Kirkpatrick_at_pharmacy.uq.edu.au>
Date: Tue, 30 Oct 2007 07:51:11 +1000

Hi James and Steve


I too am astounded that James thinks academic studies should be =
considered in a more critical light than industry studies.

Which reminded me of this little snippet from an abstracting journal =
earlier this week!

"Funding source of clinical studies affects authors' interpretation of =
results
The funding source of clinical studies affects authors' interpretation =
of results, an analysis of 504 studies examining the effects of inhaled =
corticosteroids suggests (Archives of Internal Medicine 2007:167:2047).

Manufacturer-funded trials are less likely to identify adverse effects =
of inhaled cortico-steroids than studies without pharmaceutical company =
funding, a finding partly explained by differences in trial design.
In addition, authors of manufacturer-funded trials are less likely to =
conclude that statistically significant adverse effects are clinically =
important than authors of non-pharmaceutical-funded studies, researchers =
found"

Cheers

Carl


Carl Kirkpatrick BPharm(Hons) PhD MPS
School of Pharmacy
University of Queensland
St Lucia 4073
Brisbane, Australia

Phone:  +617 33653227
Fax:     +617 33651688

URL: http://www.uq.edu.au/pharmacy/ckirkpatrick/kirkpatrick.htm

"Doing things the way we always do them isn't the answer." Richard Soley

University Provider Number: 00025B



Received on Mon Oct 29 2007 - 17:51:11 EDT

This archive was generated by hypermail 2.2.0 : Tue Nov 06 2007 - 15:08:06 EST